提供学术论文选刊润色服务
医学
医学
Paper Review Records
全部论文审稿周期
18 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
293
天
Meta‐Analysis: Enhanced Liver Fibrosis ( ELF ) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease
作者Matthew F. W. Gee; Donald B. Chalfin; Edward B. De Vol; H. Roma Levy; Artem T. Boltyenkov; Mario Gutierrez Casale; Arun J. Sanyal
作者单位1. Siemens Healthcare Diagnostics Inc Tarrytown New York USA; 2. Institute of Medical Science, Temerty Faculty of Medicine University of Toronto Toronto Ontario Canada; 3. Department of Epidemiology and Biostatistics, UCSF School of Medicine University of California San Francisco San Francisco California USA; 4. Division of Gastroenterology, Hepatology and Nutrition, Stravitz‐Sanyal Institute for Liver Disease and Metabolic Health Virginia Commonwealth University School of Medicine Richmond Virginia USA
6
天
Letter: Defining the Incremental Predictive Value of HBsAg in Hepatocellular Carcinoma Risk Prediction, Authors' Reply
作者Yi‐Fan Guo; Chang Guo; Dong Ji; Xiao‐Xia Niu
作者单位1. Senior Department of Hepatology Chinese PLA General Hospital Beijing China; 2. Peking University 302 Clinical Medical School Beijing China
98
天
Review article: Immunosuppression in Decompensated Autoimmune Hepatitis Cirrhosis ‐ To Suppress or Not to Suppress?
作者Pedro Robson Costa Passos; Valbert Oliveira Costa Filho; Guilherme Grossi Lopes Cançado
作者单位1. Center of Research and Drug Development (NPDM), Federal University of Ceará Fortaleza Ceará Brazil; 2. Biomedical Research Center (NUBIMED), Federal University of Ceará Fortaleza Ceará Brazil; 3. Hospital das Clínicas Federal University of Minas Gerais Belo Horizonte Minas Gerais Brazil; 4. Hospital da Polícia Militar de Minas Gerais Belo Horizonte Minas Gerais Brazil
11
天
8
天
Letter on: Pre‐Emptive Initiation of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema Improves Outcomes: A Randomized Controlled Trial. Authors' Reply
作者Rakhi Maiwall; Meenu Bajpai; Samba Siva Rao Pasupuleti; Neha Chauhan; Mohit Prajapati; Manya Prasad; Prashant Agarwal; Rajendra Prasad Mathur; Sherin Thomas; Shiv Kumar Sarin
作者单位1. Department of Hepatology Institute of Liver and Biliary Sciences New Delhi India; 2. Department of Statistics, Department of Applied Mathematics and Statistics Pachhunga University College, Mizoram University (A Central University) Aizawl India
107
天
Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction‐Associated Steatohepatitis—Reanalysis of Fibrosis Stage 2–3 Subset
作者Maria Mironova; Krishna Padmanabhan; David Schneider; Jörn M. Schattenberg; Rohit Loomba
作者单位1. MASLD Research Center, Division of Gastroenterology and Hepatology University of California at San Diego La Jolla California USA; 2. Madrigal Pharmaceuticals, Inc. West Conshohocken Pennsylvania USA; 3. Department of Medicine II Saarland University Medical Center Homburg Germany
312
天
Review Article: Accelerating Coeliac Disease Clinical Trials—Beyond Celiac Meeting With Industry, Academics, Patients and the FDA
作者Lisa M. Fahey; Robert Anderson; Edwin Liu; Joseph A. Murray; Marie E. Robert; Jocelyn Anne Silvester; Kate Avery; Nelson Cheinquer; Kristie Grebe; Bhargav Tulabandula; Daniel A. Leffler; Beyond Celiac Coalition
作者单位1. Children's Hospital of Philadelphia Philadelphia Pennsylvania USA; 2. University of Pennsylvania Philadelphia Pennsylvania USA; 3. International Society for the Study of Celiac Disease Groningen the Netherlands; 4. Mackay Base Hospital Mackay Queensland Australia; 5. Children's Hospital Colorado University of Colorado School of Medicine Aurora Colorado USA; 6. Mayo Clinic College of Medicine and Science Rochester Minnesota USA; 7. Yale University School of Medicine New Haven Connecticut USA; 8. Boston Children's Hospital Boston Massachusetts USA; 9. Harvard Medical School Boston Massachusetts USA; 10. Beyond Celiac Ambler Pennsylvania USA; 11. Takeda Cambridge Massachusetts USA; 12. Anokion Cambridge Massachusetts USA; 13. Navigator Medicines Cambridge Massachusetts USA; 14. Chugai Pharmaceuticals Berkeley Height New Jersey USA
7
天
Letter: Interpretation of Cognitive and Clinical Outcomes in the Randomized Trial of Rifaximin for Covert Hepatic Encephalopathy. Authors' Reply
作者Hiroki Inada; Yasuhito Tanaka
作者单位1. Department of Gastroenterology and Hepatology Faculty of Life Sciences, Kumamoto University Kumamoto Japan
50
天
Clinical Trial: Multi‐Strain Probiotic Improves Bile Acid Profile, Microbiome, and Metabolomic Parameters in Patients With History of Bile Acid Malabsorption—A Randomized, Controlled Trial
作者John A. Damianos; Ayah Matar; Paula Carlson; Irene Busciglio; Kara J. Jencks; Stephen Johnson; Ruben A. Mars; Purna C. Kashyap; W. Scott Harmsen; Michael Camilleri
作者单位1. Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology Mayo Clinic Rochester Minnesota USA; 2. Division of Computational Biology Mayo Clinic Rochester Minnesota USA
2
天
Letter: Personalised FODMAP Modulation in IBS—Towards Less Restrictive Dietary Care. Authors' Reply
作者María Fernanda Garcia‐Cedillo; María Fernanda Huerta‐de la Torre; Josealberto Sebastiano Arenas‐Martinez; Enrique Coss‐Adame
作者单位1. Gastrointestinal Motility Laboratory, Department of Gastroenterology Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City Mexico
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿96.4 天
中位数77 天